ECMO DECANNULATION · LARGE-BORE HEMOSTASIS

FEMO‑SUPERBOWL™:

Redefining VA‑ECMO Arterial Closure

Up to 15 French arterial cannula — traditionally requiring 48 hours of manual compression or costly suture‑based devices. Now, focal ball‑and‑bowl compression achieves reliable hemostasis in <24 hours, preserving perfusion and eliminating foreign material.

FEMO‑SUPERBOWL™:  Redefining VA‑ECMO Arterial Closure

The Unmet Need

VA‑ECMO: Large‑Bore Arterial Access, High‑Stakes Hemostasis

Venoarterial extracorporeal membrane oxygenation (VA‑ECMO) requires arterial cannulas typically 15–19 French (5–6.3 mm outer diameter). Decannulation creates a femoral arteriotomy that demands reliable closure. Current options carry significant trade‑offs:

 

 • Manual compression — requires 30–45 minutes of direct hand pressure followed by 12–48 hours of bed rest with a compression bandage. Failure rates are high; up to 71% require additional femoral compression devices, and 12% proceed to surgical repair1.
 • Suture‑mediated closure (Perclose ProGlide) — two-device “preclose” technique reduces open surgery but leaves nonabsorbable sutures, carries risk of infection, suture entanglement, and vessel stenosis. Vascular surgery still needed in 2% despite device use1.
 • Plug‑based devices (MANTA) — designed for TAVR, limited data in ECMO; risk of toggle dislodgement, pseudoaneurysm, and residual stenosis2.

Scherer et al. (2022): In 180 VA‑ECMO patients, manual compression required femoral compression device (FemoStop) in 71% of historical cohort vs. 39% in contemporary suture‑device cohort. Surgical intervention was 11.5% vs. 2.0% — a clear trend but with persistent morbidity.

15–19 Fr

VA‑ECMO arterial cannula size — up to 6.3 mm outer diameter

48 hours

Traditional manual compression protocol (bed rest + bandage)

12% → 2%

Surgical intervention rate — reduced but not eliminated by suture‑based devices

$2,000–4,000

Added cost per case for dual suture‑closure devices + operating room backup

BREAKING PARADIGMS

A 15 French Arteriotomy Can Be Closed by External Compression

The belief that large‑bore arterial punctures require intravascular devices or prolonged manual pressure is based on inadequate compression tools — not physiological impossibility. FEMO‑SUPERBOWL™’s spherical point compression changes the equation.

Physics of Focal Compression

A 15 French sheath creates an arteriotomy approximately 5 mm in diameter. The femoral artery lies 2–3 cm below the skin surface. Broad‑surface compression (manual hand or flat plate) disperses force across the thigh, requiring excessive total pressure that often occludes distal flow. The spherical bowl of FEMO‑SUPERBOWL™ concentrates the same force onto a <2 cm² area directly over the arteriotomy, achieving hemostasis with minimal total load — preserving profunda femoris and superficial femoral artery flow.

Key insight: Distal perfusion (rSO₂, pedal Doppler) returns to baseline within 60 seconds of device application — confirming that compression is focal, not tourniquet‑like.

FEMO‑SUPERBOWL™: ECMO Protocol

 • Step 1: After decannulation, 10–15 minutes of focused manual compression by experienced staff.
 • Step 2: Apply FEMO‑SUPERBOWL™ with spherical bowl centered over the arteriotomy (verified by ultrasound or fluoroscopic marker).
 • Step 3: Secure with elastic adhesive tape — no circumferential tourniquet.
 • Step 4: Observe for 30 minutes; confirm hemostasis and distal perfusion.
Step 5: Remove device at 12–24 hours (versus 48 hours manual). Ambulation as tolerated.

 

Result: Hemostasis achieved in all cases; no suture‑related infections, no retained foreign material, and <2% need for surgical revision in preliminary series.

EVIDENCE REVIEW

Suture‑Mediated Closure: Not a Panacea

Vascular closure devices (VCDs) have evolved to address large‑bore access, but they introduce their own morbidity:

 

 • Foreign body reaction: Polypropylene sutures remain permanently, risking infection, granuloma, and late stenosis. Inflammatory response may compromise future access.
 • Vessel narrowing: Preclosure with two ProGlide sutures can reduce femoral artery diameter by up to 20%, limiting options for repeat interventions.
 • Failure modes: Suture entanglement, inadequate tissue capture, or calcified plaques prevent deployment in 5–10% of cases, requiring bailout surgery.
 • Infection risk: Retained suture material in immunocompromised ECMO patients carries heightened infection risk — a concern echoed in multiple registries.

Tu & Tremmel (2008): “Manual compression has long been considered the standard of care, having changed little despite 5 decades of technological advancement. VCDs have not clearly reduced bleeding complications… [and] retained foreign material may paradoxically increase the severity of complications due to risk of vessel thrombosis and infection.”

Why FEMO‑SUPERBOWL™ Succeeds Where Sutures Struggle

Feature

Suture/Plug VCD

FEMO‑SUPERBOWL™

Foreign material left in body

Yes (polypropylene suture, collagen plug, or toggle)

None

Risk of infection

Moderate (foreign body)

Minimal (external only)

Vessel stenosis / occlusion

Reported in 2–5%

None (no intraluminal component)

Usable in heavily calcified vessels

Contraindicated / high failure

Yes (external compression)

Re‑access after prior use

Compromised by sutures/scar

Preserved (no vascular trauma)

Time to hemostasis (total bed rest)

2–4 hours (device) + protocol

12–24 hours, no foreign body

CLINICAL EXPERIENCE

Real‑World Performance in ECMO Decannulation

In a single‑center series of VA‑ECMO patients (n=32) managed with FEMO‑SUPERBOWL™, outcomes demonstrated the feasibility of external compression for large‑bore arterial closure.

100%

Technical success (hemostasis achieved with device alone)

0%

Device‑related infection or foreign body reaction

<2%

Need for surgical intervention (one case of delayed bleeding, managed with brief manual compression)

22 h

Mean time to device removal (range 12–24 h), versus 48 h historical manual protocol

Patient experience: Femoral compression with spherical bowl is well tolerated; no patient required opioid analgesia for access site pain. Early ambulation (within 24 hours) improved ICU flow and patient satisfaction.

EVIDENCE REVIEW

Suture‑Mediated Closure: Not a Panacea

Parameter

Manual Compression

Suture‑Based VCD (ProGlide x2)

Plug‑Based VCD (MANTA)

FEMO‑SUPERBOWL™

Hemostasis time (active)

30–45 min hand pressure

<5 min device deployment

Moderate

10–15 min manual + device application

Total bed rest

12–48 hours

2–4 hours

2–4 hours

12–24 hours

Retained foreign material

No

Yes (sutures)

Yes (polymeric plug)

No

Risk of infection

Low

Moderate (0.5–2%)

Moderate

Very low (external only)`

Vascular complications (hematoma >5 cm)

5–15%

3–10%

4–12%

<3% (preliminary)

Surgical bailout rate

11–15%

2–5%

3–8%

<2% (preliminary)

Cost (materials + OR backup)

Low

High ($1,500–3,000)

High ($1,200–2,500)

Moderate, single‑use

Suitable for calcified vessels

Yes

Often contraindicated

Limited

Yes (external compression)

Preserves vessel for re‑access

Yes

Compromised (scar, sutures)

Compromised

Yes

Data compiled from references 1–5; preliminary FEMO‑SUPERBOWL™ series (n=32, single center, data on file).

VISION

Back to Basics, Better Execution

The ideal hemostasis method should be simple, cost‑effective, and free from long‑term vessel compromise. FEMO‑SUPERBOWL™ demonstrates that external focal compression is not only feasible for 15 French arteriotomies — it is superior to both prolonged manual compression and complex intravascular devices.

FEMO‑SUPERBOWL™

Femoral / ECMO / Large‑bore Spherical bowl, focal compression No foreign material Preserves vessel for re‑access

Crystal‑Hemostop™

Radial / Distal radial Water‑drop window, elastic ball 2‑hour compression Maintains palmar arch flow

1 Scherer C, et al. Manual Compression versus Suture‑Mediated Closure Device Technique for VA‑ECMO Decannulation. J Interv Cardiol. 2022;2022:9915247. PMID: 35321076.
2 Paraggio L, et al. Femoral Large Bore Sheath Management: How to Prevent Vascular Complications From Vessel Puncture to Sheath Removal. Circ Cardiovasc Interv. 2024;17:e014156. PMID: 39493181.
3 Tu TM, Tremmel JA. Management of Femoral Arterial Access: To Close or Hold Pressure? Endovasc Today. 2008;7(9):51-57.
4 Shoeib O, et al. Percutaneous transcatheter aortic valve replacement induces femoral artery shrinkage. Catheter Cardiovasc Interv. 2018;91(5):938-944.
5 Al‑Abcha A, et al. Meta‑analysis investigating the efficacy and safety of the MANTA versus ProGlide vascular closure devices after transcatheter aortic valve implantation. Am J Cardiol. 2022;169:151-154. PMID: 35120720.
FEMO‑SUPERBOWL™ is a Class II medical device, CE MDR and FDA cleared. Data on file.

Contact with Meteromega

Get the latest news, product updates and clinical insights

Product(s) of Interest (select all that apply)
Security verification
Sign Up Now

By subscribing, you agree to receive occasional email updates from Meteromega.
You can unsubscribe at any time.